Cargando…
Test-and-treat coverage and HIV virulence evolution among men who have sex with men
HIV set point viral load (SPVL), the viral load established shortly after initial infection, is a proxy for HIV virulence: higher SPVLs lead to higher risk of transmission and faster disease progression. Three models of test-and-treat scenarios, mainly in heterosexual populations, found that increas...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893213/ https://www.ncbi.nlm.nih.gov/pubmed/33633867 http://dx.doi.org/10.1093/ve/veab011 |
_version_ | 1783653020853075968 |
---|---|
author | Stansfield, Sarah E Herbeck, Joshua T Gottlieb, Geoffrey S Abernethy, Neil F Murphy, James T Mittler, John E Goodreau, Steven M |
author_facet | Stansfield, Sarah E Herbeck, Joshua T Gottlieb, Geoffrey S Abernethy, Neil F Murphy, James T Mittler, John E Goodreau, Steven M |
author_sort | Stansfield, Sarah E |
collection | PubMed |
description | HIV set point viral load (SPVL), the viral load established shortly after initial infection, is a proxy for HIV virulence: higher SPVLs lead to higher risk of transmission and faster disease progression. Three models of test-and-treat scenarios, mainly in heterosexual populations, found that increasing treatment coverage selected for more virulent viruses. We modeled virulence evolution in a population of men who have sex with men (MSM) with increasing test-and-treat coverage. We extended a stochastic, dynamic network model (EvoNetHIV). We varied relationship patterns (MSM vs. heterosexual), HIV transmission models (increasing vs. plateauing probability of transmission at very high viral loads), and treatment roll-out (with explicit testing or fixed intervals between infection and treatment). In scenarios most similar to previous models (longer relational durations and the plateauing transmission function), we replicated trends previously found: increasing treatment coverage led to increased virulence (0.12 log(10) increase in mean population SPVL between 20% and 100% treatment coverage). In scenarios reflecting MSM behavioral data using the increasing transmission function, increasing treatment coverage selected for viruses with lower virulence (0.16 log(10) decrease in mean population SPVL between 20% and 100% treatment coverage). These findings emphasize the impact of sexual network conditions and transmission function details on predicted epidemiological and evolutionary outcomes. Varying these features creates very different evolutionary environments, which in turn lead to opposite effects in mean population SPVL evolution. Our results suggest that, under some realistic conditions, effective test-and-treat strategies may not face the previously reported tradeoff in which increasing coverage leads to evolution of greater virulence. This suggests instead that a virtuous cycle of increasing treatment coverage and diminishing virulence is possible. |
format | Online Article Text |
id | pubmed-7893213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-78932132021-02-24 Test-and-treat coverage and HIV virulence evolution among men who have sex with men Stansfield, Sarah E Herbeck, Joshua T Gottlieb, Geoffrey S Abernethy, Neil F Murphy, James T Mittler, John E Goodreau, Steven M Virus Evol Research Article HIV set point viral load (SPVL), the viral load established shortly after initial infection, is a proxy for HIV virulence: higher SPVLs lead to higher risk of transmission and faster disease progression. Three models of test-and-treat scenarios, mainly in heterosexual populations, found that increasing treatment coverage selected for more virulent viruses. We modeled virulence evolution in a population of men who have sex with men (MSM) with increasing test-and-treat coverage. We extended a stochastic, dynamic network model (EvoNetHIV). We varied relationship patterns (MSM vs. heterosexual), HIV transmission models (increasing vs. plateauing probability of transmission at very high viral loads), and treatment roll-out (with explicit testing or fixed intervals between infection and treatment). In scenarios most similar to previous models (longer relational durations and the plateauing transmission function), we replicated trends previously found: increasing treatment coverage led to increased virulence (0.12 log(10) increase in mean population SPVL between 20% and 100% treatment coverage). In scenarios reflecting MSM behavioral data using the increasing transmission function, increasing treatment coverage selected for viruses with lower virulence (0.16 log(10) decrease in mean population SPVL between 20% and 100% treatment coverage). These findings emphasize the impact of sexual network conditions and transmission function details on predicted epidemiological and evolutionary outcomes. Varying these features creates very different evolutionary environments, which in turn lead to opposite effects in mean population SPVL evolution. Our results suggest that, under some realistic conditions, effective test-and-treat strategies may not face the previously reported tradeoff in which increasing coverage leads to evolution of greater virulence. This suggests instead that a virtuous cycle of increasing treatment coverage and diminishing virulence is possible. Oxford University Press 2021-02-10 /pmc/articles/PMC7893213/ /pubmed/33633867 http://dx.doi.org/10.1093/ve/veab011 Text en © The Author(s) 2021. Published by Oxford University Press. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Stansfield, Sarah E Herbeck, Joshua T Gottlieb, Geoffrey S Abernethy, Neil F Murphy, James T Mittler, John E Goodreau, Steven M Test-and-treat coverage and HIV virulence evolution among men who have sex with men |
title | Test-and-treat coverage and HIV virulence evolution among men who have sex with men |
title_full | Test-and-treat coverage and HIV virulence evolution among men who have sex with men |
title_fullStr | Test-and-treat coverage and HIV virulence evolution among men who have sex with men |
title_full_unstemmed | Test-and-treat coverage and HIV virulence evolution among men who have sex with men |
title_short | Test-and-treat coverage and HIV virulence evolution among men who have sex with men |
title_sort | test-and-treat coverage and hiv virulence evolution among men who have sex with men |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893213/ https://www.ncbi.nlm.nih.gov/pubmed/33633867 http://dx.doi.org/10.1093/ve/veab011 |
work_keys_str_mv | AT stansfieldsarahe testandtreatcoverageandhivvirulenceevolutionamongmenwhohavesexwithmen AT herbeckjoshuat testandtreatcoverageandhivvirulenceevolutionamongmenwhohavesexwithmen AT gottliebgeoffreys testandtreatcoverageandhivvirulenceevolutionamongmenwhohavesexwithmen AT abernethyneilf testandtreatcoverageandhivvirulenceevolutionamongmenwhohavesexwithmen AT murphyjamest testandtreatcoverageandhivvirulenceevolutionamongmenwhohavesexwithmen AT mittlerjohne testandtreatcoverageandhivvirulenceevolutionamongmenwhohavesexwithmen AT goodreaustevenm testandtreatcoverageandhivvirulenceevolutionamongmenwhohavesexwithmen |